Breaking News

Rare Cancer Research Foundation Partners with Spanios to Advance Cancer Research

Aim to catalyze the discovery of new biomarkers and validate therapeutic approaches previously inaccessible to rare cancer patients.

Author Image

By: Charlie Sternberg

Associate Editor

The Rare Cancer Research Foundation (RCRF) has partnered with Spanios to advance the discovery and validation of groundbreaking therapeutic options for rare cancers. This partnership, facilitated through RCRF’s initiative, Pattern.org, marks a significant step towards addressing the pressing need for effective treatments in the realm of rare cancers.   Pattern.org, a patient-centric platform, empowers individuals battling rare cancers across the United States to donate fresh tumor tissue...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters